136 related articles for article (PubMed ID: 36028947)
1. Retrospective identification of new psychoactive substances in patient samples submitted for clinical drug analysis.
Axelsson MAB; Lövgren H; Kronstrand R; Green H; Bergström MA
Basic Clin Pharmacol Toxicol; 2022 Nov; 131(5):420-434. PubMed ID: 36028947
[TBL] [Abstract][Full Text] [Related]
2. Quantification of new psychoactive substances in Australian wastewater utilising direct injection liquid chromatography coupled to tandem mass spectrometry.
Bade R; Eaglesham G; Shimko KM; Mueller J
Talanta; 2023 Jan; 251():123767. PubMed ID: 35973252
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and
Cannaert A; Sparkes E; Pike E; Luo JL; Fang A; Kevin RC; Ellison R; Gerona R; Banister SD; Stove CP
ACS Chem Neurosci; 2020 Dec; 11(24):4434-4446. PubMed ID: 33253529
[TBL] [Abstract][Full Text] [Related]
4. Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in "legal high" products and human urine specimens.
Haschimi B; Mogler L; Halter S; Giorgetti A; Schwarze B; Westphal F; Fischmann S; Auwärter V
Drug Test Anal; 2019 Sep; 11(9):1377-1386. PubMed ID: 31228224
[TBL] [Abstract][Full Text] [Related]
5. Fatal intoxication with new synthetic cannabinoids 5F-MDMB-PICA and 4F-MDMB-BINACA-parent compounds and metabolite identification in blood, urine and cerebrospinal fluid.
Tokarczyk B; Jurczyk A; Krupińska J; Adamowicz P
Forensic Sci Med Pathol; 2022 Dec; 18(4):393-402. PubMed ID: 35699867
[TBL] [Abstract][Full Text] [Related]
6. Clinical symptoms and blood concentration of new psychoactive substances (NPS) in intoxicated and hospitalized patients in the Budapest region of Hungary (2018-19).
Institóris L; Kovács K; Sija É; Berkecz R; Körmöczi T; Németh I; Elek I; Bakos Á; Urbán I; Pap C; Kereszty É
Clin Toxicol (Phila); 2022 Jan; 60(1):18-24. PubMed ID: 34080493
[TBL] [Abstract][Full Text] [Related]
7. NPS detection in prison: A systematic literature review of use, drug form, and analytical approaches.
Vaccaro G; Massariol A; Guirguis A; Kirton SB; Stair JL
Drug Test Anal; 2022 Aug; 14(8):1350-1367. PubMed ID: 35355411
[TBL] [Abstract][Full Text] [Related]
8. Monitoring the use of novel psychoactive substances in Australia by wastewater-based epidemiology.
Jaunay EL; Bade R; Paxton KR; Nadarajan D; Barry DC; Zhai Y; Tscharke BJ; O'Brien JW; Mueller J; White JM; Simpson BS; Gerber C
Sci Total Environ; 2024 Apr; 919():170473. PubMed ID: 38286292
[TBL] [Abstract][Full Text] [Related]
9. New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"?
Napoletano S; Basile G; Lo Faro AF; Negro F
Acta Biomed; 2022 May; 93(2):e2022186. PubMed ID: 35545997
[TBL] [Abstract][Full Text] [Related]
10. [Metabolism of New Psychoactive Substances 4F-MDMB-BUTINACA in Zebrafish].
Yue LN; Xiang P; Song FY; Shen BH; Yan H
Fa Yi Xue Za Zhi; 2021 Aug; 37(4):493-499. PubMed ID: 34726001
[TBL] [Abstract][Full Text] [Related]
11. [Identification of Synthetic Cannabinoid New Psychoactive Substances 4F-MDMB-BUTINACA and MDMB-4en-PINACA].
Wang KD; Yuan XL; Zhang YR; Hu JJ; Cao FQ; Chen YS
Fa Yi Xue Za Zhi; 2021 Aug; 37(4):505-510. PubMed ID: 34726003
[TBL] [Abstract][Full Text] [Related]
12. Focusing on the 5F-MDMB-PICA, 4F-MDMB-BICA synthetic cannabinoids and their primary metabolites in analytical and pharmacological aspects.
Dvorácskó S; Körmöczi T; Sija É; Bende B; Weiczner R; Varga T; Ilisz I; Institóris L; Kereszty ÉM; Tömböly C; Berkecz R
Toxicol Appl Pharmacol; 2023 Jul; 470():116548. PubMed ID: 37182749
[TBL] [Abstract][Full Text] [Related]
13. 4F-MDMB-BINACA: A New Synthetic Cannabinoid Widely Implicated in Forensic Casework.
Krotulski AJ; Mohr ALA; Kacinko SL; Fogarty MF; Shuda SA; Diamond FX; Kinney WA; Menendez MJ; Logan BK
J Forensic Sci; 2019 Sep; 64(5):1451-1461. PubMed ID: 31260580
[TBL] [Abstract][Full Text] [Related]
14. Online surveillance of novel psychoactive substances (NPS): Monitoring Reddit discussions as a predictor of increased NPS-related exposures.
Barenholtz E; Krotulski AJ; Morris P; Fitzgerald ND; Le A; Papsun DM; Logan BK; Hahn WE; Goldberger BA; Cottler LB; Palamar JJ
Int J Drug Policy; 2021 Dec; 98():103393. PubMed ID: 34365124
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds: A Stability Assessment.
Krotulski AJ; Bishop-Freeman SC; Mohr ALA; Logan BK
J Anal Toxicol; 2021 Feb; 45(1):60-68. PubMed ID: 32435808
[TBL] [Abstract][Full Text] [Related]
16. Intoxications involving acrylfentanyl and other novel designer fentanyls - results from the Swedish STRIDA project.
Helander A; Bäckberg M; Signell P; Beck O
Clin Toxicol (Phila); 2017 Jul; 55(6):589-599. PubMed ID: 28349714
[TBL] [Abstract][Full Text] [Related]
17. New psychoactive substances in oral fluid of drivers around a music festival in south-west France in 2017.
Richeval C; Dumestre-Toulet V; Wiart JF; Vanhoye X; Humbert L; Nachon-Phanithavong M; Allorge D; Gaulier JM
Forensic Sci Int; 2019 Apr; 297():265-269. PubMed ID: 30851602
[TBL] [Abstract][Full Text] [Related]
18. Target and suspect screening of (new) psychoactive substances in South Korean wastewater by LC-HRMS.
Lee HJ; Oh JE
Sci Total Environ; 2023 Jun; 875():162613. PubMed ID: 36871726
[TBL] [Abstract][Full Text] [Related]
19. Structural characterization of the new synthetic cannabinoids CUMYL-PINACA, 5F-CUMYL-PINACA, CUMYL-4CN-BINACA, 5F-CUMYL-P7AICA and CUMYL-4CN-B7AICA.
Bovens M; Bissig C; Staeheli SN; Poetzsch M; Pfeiffer B; Kraemer T
Forensic Sci Int; 2017 Dec; 281():98-105. PubMed ID: 29125990
[TBL] [Abstract][Full Text] [Related]
20. Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples.
Mogler L; Franz F; Rentsch D; Angerer V; Weinfurtner G; Longworth M; Banister SD; Kassiou M; Moosmann B; Auwärter V
Drug Test Anal; 2018 Jan; 10(1):196-205. PubMed ID: 28371476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
